Previous 10 | Next 10 |
Shares of the Canadian pot company Aphria (NYSE: APHA) rose by an eye-catching 25.5% during the month of April, according to data from S&P Global Market Intelligence . Aphria's shares spiked last month for two fundamental reasons. First off, the company's shares were hammered in M...
May 11, 2020 Palm Beach, FL – May 11, 2020 – The CBD market surge in the last few years has been well documented and all reports seem to project continued growth of revenues over the coming years. CNN said, “These hemp farmers are getting ric...
For growth investors, the Canadian pot market has been one of the most appealing investment opportunities in the world, but it's also one of the most frustrating. It presents a whole lot of opportunity because it's the only country other than Uruguay that's legalized recreational marijuana. How...
Aphria ( APHA -6.6% ) announces that it has reduced its debt and slashed its annual cash interest expenses by C$6.7M ($4.8M) via privately negotiated agreements with holders of its convertible senior notes. More news on: Aphria Inc., Healthcare stocks news, Consumer stocks news, Stocks...
Aphria strengthens balance sheet with negotiated debt reduction Canada NewsWire LEAMINGTON, ON, May 8, 2020 Completes accretive transaction to repurchase its convertible senior notes Net cash position increases by $127.5 million ( $91 million USD ) LEAMINGTON, ON , Ma...
At this time last year, marijuana remained one of the hottest industries that investors could buy. Canada had recently legalized recreational pot, and the country was slated to introduce higher-margin derivatives later in the year. The U.S. was also expected to deliver substantive growth with la...
Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics. Introduction On April 14, Aphria ( APHA ) reported fiscal 2020 Q3 results that exceeded investor expectations. While the stock remains battered by the ongoing p...
Aphria's (NYSE: APHA ) subsidiary, ASG Pharma has received its European Union Good Manufacturing Practices ("EU GMP") certification from the Malta Medicines Authority ("MMA") in respect of production of cannabis for medicinal and research purposes. More news on: Aphria Inc., Healthcare s...
Aphria Inc. Announces Receipt of EU GMP Certification for Subsidiary ASG Pharma Ltd. and Liquidation of Promissory Note Canada NewsWire LEAMINGTON, ON, May 6, 2020 LEAMINGTON, ON , May 6, 2020 /CNW/ - Aphria Inc. (" Aphria " or the " Company ") ( TSX: APHA and ...
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary We are resuming our weekly cannabis coverage. The global pandemic has upended the global financial markets, ending the 11-year bull...
News, Short Squeeze, Breakout and More Instantly...
Cannabis Industry Merger And Acquisitions In 2021 Many cannabis stocks have over the last several months been hit with a loss in trading momentum. This has led to many of the top cannabis stocks trading at lower prices. Yet so far in May pot stocks have been performing a bit more vo...